Le Lézard
Classified in: Tourism and vacations, Transportation, Health
Subjects: PET, PSF, DIS, AVO

National Federation of the Blind Statement on Delta's New Service Animal Policy


BALTIMORE, Jan. 23, 2018 /PRNewswire-USNewswire/ -- The National Federation of the Blind stated the following with regard to the new service and support animal policy announced by Delta Air Lines on January 19:

We are deeply concerned that Delta Air Lines has taken this action without consulting the National Federation of the Blind, our division the National Association of Guide Dog Users, or any other democratically elected representative of blind Americans. Blind people have safely and successfully used guide dogs for decades, but this policy fails to make a clear or practical distinction among guide dogs, other "service and support animals" (as Delta puts it), and pets. Onerous restrictions on guide dog handlers do not resolve anything and violate the principle of equal access for passengers with disabilities. Furthermore, we believe that elements of Delta's policy, as currently articulated, violate the Air Carrier Access Act.

National Federation of the Blind logo (PRNewsFoto/National Federation of the Blind)

We are particularly troubled by the requirement that guide dog users submit paperwork to Delta forty-eight hours before flying. Travelers without guide dogs are not required to plan their travel forty-eight hours in advance. Furthermore, guide dog users will no longer be able to fly Delta in family, medical, or other emergencies. We believe that this forty-eight hour requirement is both unnecessary and unlawful.

We are asking for an urgent meeting with Delta and stand ready to work with it and other airlines to craft fair and reasonable policies to address the concerns of air carriers, their personnel, and their passengers, without imposing undue, unsupported, and unlawful hardships on guide dog users.

About the National Federation of the Blind
The National Federation of the Blind (NFB), headquartered in Baltimore, is the oldest and largest nationwide organization of blind Americans. Founded in 1940, the NFB consists of affiliates, chapters, and divisions in the fifty states, Washington DC, and Puerto Rico. The NFB defends the rights of blind people of all ages and provides information and support to families with blind children, older Americans who are losing vision, and more. We believe in the hopes and dreams of blind people and work together to transform them into reality. Learn more about our many programs and initiatives at www.nfb.org.

CONTACT:
Chris Danielsen
Director of Public Relations
National Federation of the Blind
(410) 659-9314, extension 2330
(410) 262-1281 (Cell)
[email protected]

 

SOURCE National Federation of the Blind


These press releases may also interest you

at 01:00
PARIS, FRANCE, 24 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-care biopharmaceutical company, today presents its sales for the first quarter of 2024. ? ?  Q1 2024? Q1 2023? % change? ?m? ?m? ActualCER1Growth...

23 avr 2024
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

23 avr 2024
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

23 avr 2024
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

23 avr 2024
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

23 avr 2024
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...



News published on and distributed by: